Koninklijke Philips NV (PHIA)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

€22.72

Buy

€22.97

arrow-down€-0.30 (-1.30%)

Prices updated at 12 Dec 2025, 16:38 CET
| Prices minimum 15 mins delay
|
Prices in EUR
Royal Philips NV is a health technology company. The company provides various services in the area of personal health, diagnosis and treatment, connected care and health informatics businesses, and health tech.
FTSE EuroFirst 300
arrow-down-0.53%
Amsterdam
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

0.850
Cash Dividend
12 May 2025
19 Feb 2025
13 May 2025
06 Jun 2025

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20250.8500-
2024--
2023--
20220.7868-
20210.7868-
2020--
20190.77110.06
20180.7258-
20170.7258-
20160.7258-

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20253.500.59
2024-2.47
2023-1.19
20226.0712.65
20212.590.82
2020-1.46
20191.953.79
20182.592.53
20172.54-
20162.76-

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20250.8500
2024-
2023-
20220.7868
20210.7868
2020-
20190.7711
20180.7258
20170.7258
20160.7258

% of earnings paid to shareholders data table

YearPayout ratio (%)
2025531.25
2024-
2023-
2022-
202173.28
2020-
201958.22
201888.89
201761.54
2016197.74
Latest Financial Report as of 12 Dec 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.